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Objectives To study trovafloxacin susceptibility among clinical isolates of four anaerobic bacterial species
using minimum inhibitory concentrations (MIC) determinations, E test assays and disk diffusion test results
and to calibrate the disk diffusion method for these species using single strain regression analysis (SRA).
Methods One-hundred and eighty-seven clinical isolates of four anaerobic bacterial species were included.
Trovafloxacin MIC determinations were performed using the agar dilution technique and MIC estimations
using the E test. The disk diffusion test was performed according to Swedish Reference Group for Antibiotics
standardization. NCCLS limits for susceptibility categories were applied. SRA was performed using 1, 3, 10,
30, and 100 mg trovafloxacin disk contents and ATCC control strains. The regression lines obtained permitted
the calculation of zone equivalents to MIC limits as well as an evaluation of various disk potencies.
Results Trovafloxacin susceptibility (S + I) was noted in 98.9, 100, 100, and 97% of Bacteroides fragilis,
Bacteroides thetaiotaomicron, Clostridium perfringens, and Peptostreptococcus magnus strains, respectively, as judged by
MIC determinations. Agar dilution and E test estimations gave the same results, but E test values were
consistently lower than MIC values by the reference method. Regression lines calculated for the four species
using SRA showed different equation constants indicating species-related differences. Interpretive zone
diameter breakpoints were calculated for the four species and used for the interpretation of susceptibility.
Conclusions The disk diffusion test was successfully calibrated for trovafloxacin susceptibility testing of four
anaerobic species using single strain regression analysis, SRA. There was a good agreement between the results
of MIC-tests and disk testing. Interpretive errors of type I are prone to occur among Bacteroides isolates and
might require species-related MIC limits. SRA calculations permitted the testing of the effect of different disk
potencies on inhibition zones produced at the interpretive MIC limits. Criteria for the selection of a minimal
disk content showed that 5 mg trovafloxacin is sufficient, but a 10 mg disk will safeguard against residual
laboratory variation without producing too large inhibition zones for very susceptible strains.
Keywords antibiotic susceptibility testing, disk diffusion test, calibration, regression line, interpretive zone
breakpoint, trovafloxacin susceptibility, quality control
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INTRODUCTION
Among the newer fluoroquinolones, trovafloxaxcin (CP
99,219) shows improved efficacy not only against Gram-posi-
tive and Gram-negative aerobic organisms [1–3] but also against
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anerobic bacteria [4–6]. With relatively few side-effects and a
rather complete antibacterial coverage, trovafloxacin therefore
seems to be a very promising fluoroquinolone with a wide
range of indications, including serious invasive infections [6].
Because of the broader antibacterial spectrum of trovafloxacin,
in-vitro antibiotic susceptibility test results for other fluoro-
quinolones cannot always be used as guidelines also for
trovafloxacin. Susceptibility testing might therefore be recom-
mended with trovafloxacin.
Disk diffusion methods for susceptibility testing of anaerobes
to various antibiotics are not always standardized or recom-
mended and the disk diffusion method is therefore not used as
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widely as it deserves [7] provided it can be calibrated properly
[8]. The present studies were performed to evaluate a calibration
method for trovafloxacin susceptibility testing of anaerobic iso-
lates and to study trovafloxacin susceptibility among rapidly
growing anaerobes in Sweden using minimum inhibitory con-
centration (MIC) testing with the agar dilution method, MIC
estimation using the E test and the calibrated disk diffusion
method.
MATERIALS AND METHODS
Bacterial strains
Clinical isolates of anaerobic bacteria were collected from rou-
tine specimens received at the Clinical Microbiology Labora-
tory, University Hospital of Lund, Lund, Sweden. The 187
strains included 89 isolates of Bacteroides fragilis, 22 isolates of
Bacteroides thetaiotaomicron, 41 isolates of Clostridium perfringens,
and 35 strains of Peptostreptococcus magnus. Species identification
followed established procedures [9,10]. All strains were sub-
cultured and stored on Fastidious anaerobe agar (Lab M, Topley
House, Wash Lane, Bury, England) in Gas Pack jars (BBL) at
room temperature until testing. The strains had experienced
2–4 passages before testing. Control strains Bacteroides fragilis,
ATCC 25285, Bacteroides thetaiotaomicron, ATCC 29741, Clo-
stridium perfringens, ATCC 13124, and Peptostreptococcus magnus,
ATCC 29328, were included for MIC determinations and disk
diffusion tests and also for single-strain regression analysis (SRA)
to calibrate the disk test.
MIC determinations
The MIC of trovafloxacin for clinical isolates of anaerobic
pathogens and for control strains was determined using the agar
dilution method [11]. MICs were determined by incorporating
the antibiotics in PDM agar medium (AB Biodisk, Solna,
Sweden) supplemented with 5% horse blood, vitamin K, and
hemin. Supplemented PDM agar plates containing two-fold
dilutions of trovafloxacin were prepared and used on the same
day. The inoculum was prepared by suspending colonies from
a 48 h culture plate into Fastidious anaerobe broth (F.A.B. Lab
71; Lab M, ) to a visible turbidity of a no. 0.5 McFarland
standard. Using a Steers’ replicator, 10 mL of the bacterial sus-
pension was applied to the plate with a final inoculum of
approximately 105 CFU per spot. The plates were incubated at
35–37 °C in an anaerobic cabinet for 48 h. The MIC was
defined as the lowest concentration of antibiotic that inhibited
visible growth.
MIC limits for interpretation of susceptibility were S  1.0,
R  4.0 mg/L for trovafloxacin according to Swedish Ref-
erence Group for Antibiotics (SRGA) or S  2.0,
R  8.0 mg/L according to NCCLS recommendations. The
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German DIN guidelines recommend S  1.0, R  4.0 mg/L,
but other German studies favour S  2.0, R  8.0 mg/L [12].
MIC50 and MIC90 values for populations of strains represent
the MIC of 50% and 90% of the strains, respectively. When
MIC-values constituted a single homogeneous population and
included more than two dilution values, the MIC50 and MIC90
values were also calculated using probit analysis of the dis-
tribution for more exact intrapolation [13]. These values are
called MIC50P and MIC90P.
E test
For the E test (AB Biodisk), prereduced supplemented PDM
plates were used. The inoculum (approximately 108 CFU/mL)
was the same as used for the agar dilution tests. The inoculum
was applied with a sterile cotton swab streaked in two crossing
directions and then allowed to be absorbed for 10 min before
the antibiotic strip was applied. The plates were incubated at
35–37 °C in an anaerobic cabinet and evaluated after 24 and
48 h. The MIC was read from the scale at the intersection of
the zone with the strip according to the instructions of the
manufacturer.
Disk diffusion antibiotic susceptibility testing
The antibiotic susceptibility of clinical isolates was determined
by the disk diffusion method according to SRGA [11] with
interpretations adjusted for species groups when applicable
[14,15]. Suspensions of the bacterial isolates were inoculated
on prereduced supplemented PDM agar using cotton swabs
streaked on the medium in two crossing directions. The inocu-
lum (approximately 108 CFU/mL) was the same as used for the
agar dilution tests and the E tests. After absorption of the
inoculum, the antibiotic disks were applied followed by pre-
incubation at room temperature for 15–20 min. The plates
were then incubated at 35–37 °C in an anaerobic cabinet and
evaluated after 24 and 48 h.
Both SRGA and NCCLS recommend a trovafloxacin disk
content of 10 mg whereas German DIN propose a 5-mg disk
[12]. Trovafloxacin disks were provided by Pfizer AB (Ta¨by,
Sweden). Inhibition zone diameter values were read with a pair
of calipers, in millimetres to one decimal place. Zone diameter
values were plotted species-wise for the different antibiotics as
histograms with zone values (as integers) on the X-axis and per
cent strains on the Y-axis [16,17].
Single strain regression analysis
Antibiotic disks were produced with five different trovafloxacin
disk contents: 1, 3, 10, 30, and 100 mg. The production of these
disks followed methods used since the 1960s in the Karolinska
hospital laboratory [18]. The four control strains were tested
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against these disks five to eight times (five times is
recommended, three is a minimum) on different occasions. The
test procedure for SRGA disk tests followed the recom-
mendations for regular disk diffusion tests [11,15,19]. It is
emphasized that SRA should be performed using exactly the
same procedure as the routine disk tests in order to truly reflect
the routine test results for correct calibration. Trovafloxacin
MIC values for the reference strains were determined by
repeated tests on different occasions by the agar dilution method
according to SRGA standardization as described above. Tro-
vafloxacin MIC values were 0.39 mg/L for Bacteroides fragilis,
ATCC 25285; 0.85 mg/L for Bacteroides thetaiotaomicron, ATCC
29741; 0.15 mg/L for Clostridium perfringens, ATCC 13124; and
0.125 for Peptostreptococcus magnus, ATCC 29328.
SRA equation constants A and B were calculated using
computer software. Constants A and B for the four reference
strains were then used for calculations of interpretive zone
breakpoints corresponding to MIC limits set for the sus-
ceptibility categories. The zone diameter equivalents to MIC
values on either side of the S, susceptible, or R, resistant, limit
were calculated and the mean value of these inhibition zones
around the limit were then adjusted to the nearest higher integer
for the S-limit and to the nearest lower integer for the R-limit,
as described earlier [20].
Evaluation of zone breakpoints
The evaluation of inhibition zone breakpoints for the sus-
ceptibility categories, S, I, and R, was performed using error
rating according to NCCLS. Minor discrepancy is defined as an
intermediate result by one method and either susceptible or
resistant by the other. Major discrepancy is defined as a true
susceptible result but resistance according to the other method.
A very major discrepancy is a true resistant result which is read as
susceptible by the disk diffusion method. The rates of these
discrepancies were calculated for the different species and the
MIC values from agar dilution tests compared with interpret-
Table 1 Results of trovafloxacin minimum inhibitory concentration (MIC) determinations using the agar dilution method and
the E test. The susceptibility rate was determined according to NCCLS MIC limits, S  2.0, R  8.0 mg/L, for anaerobic
isolates of four different species, and expressed as per cent susceptible (S + I) strains (actual numbers out of total number of
isolates shown in parenthesis)
Species MIC50 (MIC50P) MIC90 (MIC90P) Susceptible
Bacteroides fragilis MIC 0.5 (0.34) 1.0 (1.18) 98.9% (88/89)
E test 0.25 (0.10) 0.5 (0.68) 98.9% (88/89)
B. thetaiotaomicron MIC 0.5 (0.57) 2.0 (1.38) 100% (22/22)
E test 0.5 (0.36) 1.0 (0.85) 100% (22/22)
Clostridium perfringens MIC 0.125 (0.09) 0.5 (0.19) 100% (41/41)
E test 0.125 (0.08) 0.5 (0.25) 100% (41/41)
Peptostreptococcus magnus MIC 0.25 (0.16) 0.5 (0.33) 97% (34/35)
E test 0.125 (0.11) 0.5 (0.36) 97% (34/35)
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ations using the calculated zone breakpoints. Plotting of inhi-
bition zone diameter values against 10-log MIC for the clinical
isolates was performed species-wise according to mathematical
principles with the independent variable MIC on the X-axis
[21].
Evaluation of optimal disk content of antibiotic for disk diffusion
tests
SRA permits the calculation of zone diameters for various MIC
values and different disk contents. The effect of different disk
contents for routine testing was therefore performed. A rational
definition of criteria for such an optimal disk content has been
presented as the lowest disk content of antibiotic which will
distinguish resistant strains of any bacterial species from strains
of the intermediate or susceptible category [22,23]. The conse-
quence of such a definition is that the disk chosen must produce
inhibition zones for all strains belonging to the intermediate or sus-
ceptible category. It is possible to test this criterion using SRA.
RESULTS
Antibiotic susceptibility of clinical isolates of anaerobic bacteria
Trovafloxacin MIC determinations were performed on 89 iso-
lates of B. fragilis, 22 B. thetaiotaomicron, 41 C. perfringens, and
35 P. magnus, a total of 187 anaerobic strains (Table 1). Using
the NCCLS interpretive MIC limits for trovafloxacin, S  2.0,
R  8.0 mg/L, the resistance rate was 1.1% among B .fragilis
(1/89), no resistance was noted among B. thetaiotaomicron
(0/22), and C. perfringens (0/41), and 3% resistance among P.
magnus (1/35). The MIC50 and MIC90 values were also very
favourable (Table 1). E test estimations of MIC values gave the
same resistance rates. The numerical values of the E test results
were lower than the MIC-values determined by the stan-
dardized agar dilution method by a factor of (mean values) 0.52,
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Figure 1 Regression lines for trova-
floxacin (10 mg disk) and four anaerobic
species, B. fragilis, B. thetaiotaomicron,
C. perfringens, and P. magnus, as deter-
mined using single strain regression
analysis, SRA. Lines are curved because
the calculations are performed on zone
size squared for improved accuracy. MIC
values are shown as 2-log + 9 where4
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0.59, 0.70, and 0.83, for isolates belonging to the four species,
respectively.
Calibration of the disk diffusion method
Since the disk diffusion test is a more practical alternative to
MIC determinations in clinical microbiology, we applied
SRGA standardization of the disk diffusion method for testing
anaerobic bacterial isolates included in our studies. The 10-mg
trovafloxacin disk diffusion test was first calibrated as follows.
SRA calculations were performed for the four reference strains
of the four anaerobic species included. These experiments
showed that the regression lines for the four reference strains
were slightly different (Figure 1). Bacteroides fragilis and C. per-
fringens gave slope constants which were lower than the slope
constants for the other two species, B. thetaiotaomicron and P.
magnus (Table 2).
The zone diameter equivalents of MIC values around the
MIC limits for the susceptibility categories were then calculated
(Table 2). Corresponding to the differences in regression lines,
the calculated zone breakpoints differed between the four spec-
ies by up to 5–6 mm (Table 2). In order to apply these zone
breakpoints to the present studies, the inhibition zone diameter
values from disk testing of the 187 clinical isolates were plotted
against the corresponding MIC values. For the Bacteroides iso-
Table 2 Single strain regression analysis (SRA) constants and inhibition zone equivalents of minimum inhibitory concentration
(MIC)-values 1–8 mg/L. The interpretive zone diameter breakpoints according to NCCLS and SRGA MIC limits are shown
as calculated according to Forsberg et al. [20]
Species Constant A Constant B 1 mg/L 2 mg/L 4 mg/L 8 mg/L S1 R1 S2 R2
Bacteroides fragilis 329.1 429.2 27.5 25.7 23.7 21.5 25 22 27 24
B. thetaiotaomicron 446.6 280.6 27.0 24.3 21.4 18.0 23 19 26 22
Clostridium perfringens 265.8 282.6 23.4 21.6 19.7 17.6 21 18 23 20
Peptostreptococcus magnus 536.2 369.8 30.1 27.3 24.1 20.5 26 22 29 25
1 NCCLS limits for trovafloxacin susceptibility, S  2.0, R  8.0 mg/L.
2 SRGA limits for trovafloxacin susceptibility, S  1.0, R  4.0 mg/L.
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lates the number of strains having MIC values close to the MIC
limits was fairly high. Bacteroides fragilis and B. thetaiotaomicron
showed 21.4 and 31.8% of the strains with an MIC value of
1 mg/L, and 4.5 and 13.6% at 2 mg/L, respectively. This will
obviously give rise to interpretive errors of type I [24]. The
SRGA interpretive MIC limits for trovafloxacin are more prone
to such errors than the NCCLS MIC limits. Trovafloxacin
susceptibility according to uncorrected disk diffusion test results
can therefore be expected to give rise to interpretive errors
among Bacteroides isolates.
Disk diffusion test results
Using the NCCLS limits, the application of the calculated zone
breakpoints for a 10-mg trovafloxacin disk (Table 2) to the
Bacteroides isolates gave a correct interpretation in 92.1 and
68.2% of B. fragilis and B. thetaiotaomicron, respectively. For C.
perfringens and P. magnus the interpretation was correct in 100
and 91.4%, respectively. There were no very major errors for
the four species tested against trovafloxacin. Major errors were
recorded in 2.2% for B. fragilis, in 4.5% (1/22 strains) for B.
thetaiotaomicron, and in no cases for the isolates belonging to the
other two species. Minor errors were seen in 5.6, 27.3, and
8.6% for B. fragilis and B. thetaiotaomicron and P. magnus, respec-
tively. The expected interpretive errors among Bacteroides iso-
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lates were therefore confirmed in these disk diffusion tests. For
B. thetaiotaomicron the errors are not acceptable and the MIC
limits have to be corrected for this species, in a direction
determined by relevant clinical trials and correlations to MIC
data, tentatively providing zone breakpoints 3 mm lower than
the present calculated ones [24]. However, the calculation of
interpretive breakpoints using SRA provided an accurate
reflection of the present interpretive MIC limits and the method
therefore offers a new tool for the individual laboratory to set
up a standardized and calibrated disk diffusion method also for
anaerobic bacteria.
Choice of disk content for routine disk diffusion testing
The SRA calculations also permit a theoretical consideration
of various disk contents for testing of anaerobes in clinical
microbiology. The basic criterion is given above under
Materials and Methods and it requires that measurable zones
are produced around the disk by all species for all S and I isolates
[22]. The inhibition zones corresponding to the NCCLS limit
for resistance, 8 mg/L, are shown in Figure 2 for the four species
and for different disk contents. It is clear that neither B. fragilis
nor C. perfringens isolates would pose any problems (Figure 2).
However, the more steep regression lines for the other two
species (Figure 1) give almost no zones for MIC 8 mg/L with
a 2 mg trovafloxacin disk (Figure 2). The 5 mg disk would be
able to give zones for intermediate strains (4 mg/L) of B. theta-
iotaomicron taking into account a methodological variation of
21 MIC dilution steps. Peptostreptococcus magnus isolates would
be less critical. A 10-mg disk would be safer without introducing
too large zones for more susceptible isolates. For testing ana-
erobes belonging to the species studied, both the 5 and the
10 mg disks should produce accurate results.
DISCUSSION
Trovafloxacin is a fluoroquinolone antibiotic which is active
against anaerobic human pathogens [5,6,25]. This was also
Figure 2 Calculated inhibition zone dia-
meters corresponding to an MIC value
of 8 mg/L for different disk contents and
using species-specific regression lines
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shown in the present studies where 98.9, 100, 100, and 97% of
B. fragilis, B. thetaiotaomicron, C. perfringens, and P. magnus strains,
respectively, were susceptible (S + I) as judged by MIC deter-
minations. Trovafloxacin compares well with other potent anti-
biotic drugs, but has a broader range of action than most other
fluoroquinolone drugs. It might be used as monotherapy in
intra-abdominal infections, which often start off with aerobic
Enterobacteriacae such as E. coli, and then switch to obligate
anaerobes such as B. fragilis in a second phase. Its proper place
in the anti-infective arsenal remains to be seen.
Standardization of antibiotic susceptibility testing of non-
fastidious aerobic isolates using the disk diffusion method has
been well supported by several reference authorities over the
years. Similar efforts have been largely lacking when it comes
to disk diffusion testing of anaerobes. However, studies have
shown promising results for disk testing of rapidly growing
anaerobes [7,8]. Also, trovafloxacin disk diffusion tests of ana-
erobes has been described [25]. Since the major problem with
disk testing is associated with deviations from the reference
laboratory in methodology as well as in performance of indi-
vidual bacterial species, the accuracy of the disk test can be
improved with laboratory-specific regression lines and species-
related interpretations [14,15,17,24]. We have therefore used
SRA to calibrate the disk diffusion test for the four different
anaerobic species studied [15,19]. The SRA experiments per-
mitted the calculation of interpretive zone breakpoints accord-
ing to recommended MIC limits (NCCLS) and according to
species-specific regression lines.
When a new antibiotic is introduced it is necessary to deter-
mine which disk content should be used for routine disk dif-
fusion tests in microbiology laboratories. Usually, different
contents of antibiotic are tested and their performance evaluated
using a panel of clinical isolates. However, no clear criteria for
the optimal choice have been defined. We have used a recently
presented definition of the optimal disk content of antibiotic —
the lowest disk content of antibiotic which will distinguish
resistant strains from those of the intermediate or susceptible
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category [22]. This definition is possible to apply with the aid
of SRA calculations. Our results showed that it would be
possible to use a 5-mg trovafloxacin disk. However, considering
some residual variation in laboratory performance, the 10-mg
trovafloxacin disk would be safer without giving rise to too
large inhibition zones for susceptible isolates. Both disk contents
have been advocated by others [12,25].
The trovafloxacin MIC results for Bacteroides isolates showed
that MIC50 and MIC90, 0.5 and 1–2 mg/L, respectively, were
close to the interpretive limits, S  2.0, R  8.0 mg/L. It was
therefore postulated that interpretive errors of type I might
occur when performing disk diffusion tests [24]. Such was
actually the case and it was concluded that the MIC limits for
Bacteroides isolates should be species-related. However, even
without such corrective measures, which also have been advo-
cated and implemented by SRGA, the susceptibility figures
were in line with the favourable activity of trovafloxacin
according to MIC values (Tables 1, 2) [14,24]. Another situ-
ation which might require species-related interpretive MIC-
limits, is not of a strict methodological nature. Clostridium per-
fringens isolates showed an MIC50 value of 0.125 mg/L, which
is much lower than the MIC limit of S  2.0 mg/L. If some
resistance mechanism gives a 10-fold rise in the MIC, then the
strain will still be labelled trovafloxacin susceptible. It is not
advisable to recommend the drug in such a situation. A lowering
of the MIC limit for this bacterial species might safeguard
against such abuse.
A small but consistent discrepancy between MIC results
from agar dilution tests and E test estimations was noted. The
E test values were always lower, down to 50% of the reference
MIC values. Such discrepancies have been described by several
authors for other antibiotics and aerobic as well as anaerobic
isolates [26–28], both towards higher values [29–31] and lower
values [32,33]. Basically, the E test is a diffusion method and it
was originally described and patented by Professor Olof Ves-
terberg (Swedish Patent no. 403 382) and then developed by
Biodisk AB to a commercial product [34]. It consists of a
continuous gradient of antibiotic and it is widely used for
susceptibility testing of anaerobes [26,27,33,35–37]. Since both
the E test and the disk test are diffusion methods, it is clear that
whenever the E test can be used, it should also be possible to
apply the regular disk diffusion test. This is particularly true
when interpretive zone breakpoints can be set for anaerobes
and other fastidious species by calibration of the disk test in the
laboratory using SRA.
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